Showing results (11-20 of 331) with videos related to
Sort By:
Pageof 34
Genetic Epidemiology|January 18, 2008
Increasing the power of identifying gene x gene interactions in genome-wide association studiesCharles Kooperberg, Michael LeblancClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2012
Choosing phase II endpoints and designs: evaluating the possibilitiesMichael LeBlanc, Catherine TangenJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2006
Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer?David J Adelstein, Michael LeblancJournal of the Royal Statistical Society. Series C, Applied Statistics|June 4, 2020
Case-only trees and random forests for exploring genotype-specific treatment effects in randomized clinical trials with dichotomous endpointsJames Y Dai, Michael LeBlancClinical Trials (London, England)|February 20, 2008
Interim futility analysis with intermediate endpointsBryan Goldman, Michael LeBlanc, John CrowleyStatistics in Biosciences|January 3, 2018
Structured detection of interactions with the directed lassoHristina Pashova, Michael LeBlanc, Charles KooperbergClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Multiple Histology Phase II TrialsMichael Leblanc, Cathryn Rankin, John CrowleyStatistical Methods in Medical Research|July 4, 2002
Partitioning and peeling for constructing prognostic groupsMichael LeBlanc, Joth Jacobson, John CrowleyBiostatistics (Oxford, England)|June 24, 2005
Extreme regressionMichael LeBlanc, James Moon, Charles KooperbergPageof 34